Patent details

EP3400239 Title: TETRAVALENT ANTI-PSGL-1 ANTIBODIES AND USES THEREOF

Basic Information

Publication number:
EP3400239
PCT Application Number:
US2017012621
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177364783
PCT Publication Number:
WO2017120534
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TETRAVALENT ANTI-PSGL-1 ANTIBODIES AND USES THEREOF
French Title of Invention:
ANTICORPS TÉTRAVALENTS CONTRE PSGL-1 ET UTILISATIONS DE CES DERNIERS
German Title of Invention:
TETRAVALENTE ANTI-PSGL-1-ANTIKÖRPER UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
06/01/2017
Grant date:
02/06/2021
EP Publication Date:
14/11/2018
PCT Publication Date:
13/07/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/06/2021
EP B1 Publication Date:
02/06/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/01/2022
Expiration date:
06/01/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/05/2021
 
 

Name:
AltruBio Inc.
Address:
1209 Orange Street, Wilmington, New Castle County, DE 19801, United States (US)

Inventor

1

Name:
LIN, Rong-Hwa
Address:
United States (US)

2

Name:
LIN, Shih-Yao
Address:
Taiwan (TW)

3

Name:
TSAI, Yu-Ying
Address:
Taiwan (TW)

Priority

Priority Number:
201662276806 P
Priority Date:
08/01/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/18; A61K 39/395; A61P 29/00;

Publication

European Patent Bulletin

Issue number:
202122
Publication date:
02/06/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages